健康社会决定因素与MASLD患者全因及病因特异性死亡率的关联
该研究基于2007-2016年美国NHANES数据,纳入12,321名MASLD患者,随访至2019年,分析健康社会决定因素(SDoH)评分与死亡率的关联。中位随访7.6年,SDoH评分每增加1分,全因死亡风险增加32%(HR 1.32,95%CI 1.25-1.38),心血管死亡增加29%(HR 1.29,95%CI 1.19-1.40),癌症死亡增加21%(HR 1.21,95%CI 1.07-1.36)。
要点
- SDoH评分与MASLD患者全因死亡率呈剂量依赖关系。
- SDoH评分每增1分,心血管死亡风险增29%,癌症死亡增21%。
- 就业、食物保障、收入、保险和婚姻状态独立关联全因死亡。
核心结论
- SDoH评分与MASLD患者全因及病因特异性死亡率呈剂量依赖性正相关。
研究设计与样本
- 回顾性分析2007-2016年NHANES中12,321名MASLD患者,随访死亡率至2019年,采用Cox回归模型。
主要发现
- 中位随访7.6年,SDoH评分每增1分,全因死亡HR 1.32(95%CI 1.25-1.38)。
- 心血管死亡HR 1.29(95%CI 1.19-1.40),癌症死亡HR 1.21(95%CI 1.07-1.36)。
- 就业状态、食物不安全、家庭收入、私人保险覆盖和婚姻状态独立关联全因死亡。
关键数值与推荐
- SDoH评分每增加1分,全因死亡风险增加32%(HR 1.32,95%CI 1.25-1.38)。
- 心血管死亡风险增加29%(HR 1.29,95%CI 1.19-1.40)。
- 癌症相关死亡风险增加21%(HR 1.21,95%CI 1.07-1.36)。
临床怎么用
- 临床评估MASLD患者时应考虑SDoH评分,识别高风险个体并针对性干预。
局限性
- 回顾性设计,SDoH评分基于问卷,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Social determinants of health (SDoH) are the preventable health inequities, and the associations between SDoH and health outcomes among individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) remain unclear. AIMS: We investigated the relationship between SDoH and mortality in individuals with MASLD in the US. METHODS: We conducted a retrospective analysis using data from the 2007-2016 National Health and Nutrition Examination Survey, with follow-up mortality data assessed through 2019. SDoH score was derived from questionnaires, and MASLD was defined using non-invasive panels and cardiometabolic criteria. Cox regression models were used to evaluate the association between SDoH and all-cause/cause-specific mortality among individuals with MASLD. RESULTS: We analysed 12,321 individuals with MASLD (mean age: 47.0 years; 48.4% males). Over a median follow-up period of 7.6 years, higher SDoH scores were associated with progressively increased hazards of all-cause mortality. The results remained consistent in a multivariable model. Additionally, higher unfavourable SDoH scores were associated with increased cardiovascular and cancer-related mortality. Specifically, there was a 32% increase in hazards for all-cause mortality (hazard ratio [HR]: 1.32, 95% confidence interval [CI]: 1.25-1.38) and increases of 29% and 21% for cardiovascular (HR: 1.29, 95% CI: 1.19-1.40) and cancer-related mortality (HR: 1.21, 95% CI: 1.07-1.36), respectively, for each one-point increase in SDoH score. Employment status, food insecurity, family income, private insurance coverage, and marital status were independently associated with all-cause mortality in individuals with MASLD. CONCLUSIONS: This US population-based study demonstrates that SDoH scores are dose-dependently associated with increased all-cause/cause-specific mortality among individuals with MASLD.
引用
- Kim D, Danpanichkul P, Wijarnpreecha K, et al. Social Determinants of Health in Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause/Cause-Specific Mortality. Aliment Pharmacol Ther. 2025. PMID: 41090478. doi:10.1111/apt.70409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。